Rationale: Fibrillation/defibrillation episodes in failing ventricles may be followed by action potential duration (APD) shortening and recurrent spontaneous ventricular fibrillation (SVF).
lectrical storm describes a clinical condition in which the patients experience recurrent spontaneous ventricular fibrillation (SVF) requiring multiple defibrillation shocks within a short period of time. 1 It occurs frequently in patients with heart failure (HF) and is an important reason for rehospitalization. [2] [3] [4] In addition, recurrent SVF occurs in roughly half of the patients undergoing cardiopulmonary resuscitation and may be associated with significant morbidity and mortality. 3, 4 The mechanisms of electrical storm remain unclear. We recently developed a rabbit model of electrical storm with pacing-induced HF. 5 In that model, acute but reversible postshock action potential duration (APD) shortening induced recurrent SVF by promoting late phase 3 early afterdepolarizations (EADs) and triggered activity. However, the mechanisms underlying acute APD shortening after fibrillation/defibrillation episodes in failing ventricles remain unclear. Because VF is associated with intracellular Ca 2ϩ (Ca i ) accumulation, especially in failing ventricles, 6 -8 we hypothesized that apamin-sensitive smallconductance Ca 2ϩ -activated K ϩ (SK) channels may be responsible, in part, for postshock APD shortening. Apamin is a neurotoxin that selectively blocks SK channels. 9, 10 Several studies show that apamin-sensitive K ϩ current (I KAS ) is abundantly present in cardiac atrial cells but not in normal ventricular cells. 10 -16 We were unable to find any studies on I KAS regulation in heart failure (HF) ventricles. Therefore, we studied normal and HF rabbits to test the hypotheses that I KAS is significantly increased in HF rabbit ventricular myocytes and that I KAS blockade prevents postshock APD shortening and recurrent SVF in Langendorff-perfused HF ventricles.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
New Zealand White rabbits (Nϭ39) were used in the study. Among them, 5 died during rapid pacing, 22 were used for optical mapping (including 12 with pacing-induced HF, 3 sham with pacemaker implanted but not paced and 7 normal control) and 12 were used for patch clamp studies (6 HF and 6 normal control).
Optical Mapping Studies
We simultaneously mapped intracellular Ca 2ϩ (Ca i ) and membrane potential (V m ) using Rhod-2 AM and RH237, respectively, in ventricles of Langendorff-perfused hearts. Rapid ventricular pacing and 3 to 5 ventricular fibrillation (VF)-defibrillation episodes were mapped. Apamin (1 mol/L) was added to the perfusate for 30 minutes before the same protocols were repeated. We then waited for 30 minutes to determine whether the effects of apamin can be washed out.
Patch Clamp Studies
Whole-cell patch-clamp technique was used to record apaminsensitive K ϩ currents (I KAS ) in isolated ventricular cardiomyocytes. All experiments were performed at 36°C. To study Ca 2ϩ -dependence of I KAS , various combinations of EGTA and CaCl 2 were used in the pipette solutions.
Real-Time PCR
Ventricular tissues were sampled from 5 normal and 5 HF rabbits before cell isolation for patch-clamp studies. Real-time PCR was performed using iQ SYBR Green Supermix with iCycler (Bio-Rad, Hercules, CA).
Statistical Analyses
Statistical analyses were performed using SPSS PASW Statistics 17 software (IBM, Chicago, IL). We used Student t test for a comparison between 2 groups. One-way ANOVA with post hoc Bonferroni tests were performed for comparisons among 3 or more groups. A PՅ0.05 was considered as statistically significant.
Results

Evidence of HF
All rabbits that survived the rapid pacing protocol showed clinical signs of HF, including appetite loss, tachypnea, lethargy, pleural effusion, ascites, and visible congestion of lung, liver, and gastrointestinal tract. Echocardiograms of sham-operated rabbits (Nϭ3) at baseline and at second surgery showed no changes of left ventricular (LV) end-diastolic dimension (12.5Ϯ0.9 mm versus 13.0Ϯ0.6 mm), endsystolic dimension (6.5Ϯ1.5 mm versus 6.9Ϯ1.7 mm), or fractional shortening (0.49Ϯ0.08 versus 0.48Ϯ0.11) (PϭNS for all comparisons). In contrast, HF rabbits (Nϭ13) showed significant increases in end-diastolic dimension (14.5Ϯ 0.2 mm versus 19.9Ϯ0.5 mm) and in end-systolic dimension (8.4Ϯ0.3 mm versus 17.9Ϯ0.3 mm) and reduced fractional shortening (0.42Ϯ0.01 versus 0.10Ϯ0.01) (PϽ0.05 for all comparisons). The percent LV fibrosis was 5%Ϯ1% for normal (Nϭ3) or sham-operated hearts and 21%Ϯ6% for failing hearts (Nϭ5) (PϽ0.05). Action potential duration measured at 80% repolarization (APD 80 ) with pacing cycle length (PCL) of 300 ms were not different between shamoperated and normal rabbits (166Ϯ5 ms versus 168Ϯ2 ms, PϾ0.05). Therefore, these data were combined into a single nonfailing group. There were no significant differences in RR intervals during the sinus rhythm (SRm) between nonfailing and failing hearts (464Ϯ38 ms versus 509Ϯ42 ms, PϭNS). Figure 1A shows marked cardiac enlargement (right) typical for all failing hearts. Action potential duration (APD) prolongation was present in all failing ventricles. Figure 1B shows APD 80 at 300 ms PCL recorded from the site marked by an asterisk in APD 80 maps in Figure 1C . Overall, the failing ventricles (Nϭ7) had a longer APD 80 than nonfailing ventricles (Nϭ7) (181Ϯ5 ms versus 167Ϯ2 ms, PϽ0.05; Figure  1D ). The Ca i transient duration at 80% repolarization (Ca i TD 80 ) was 184Ϯ5 ms for failing ventricles and 176Ϯ3 ms for nonfailing ventricles (PϭNS).
Effects of Apamin on Acute APD Shortening and Postshock SVF
After fibrillation/defibrillation episodes, acute but transient shortening of APD occurred in all 12 failing ventricles. Three of them developed SVF in the postshock period (the "SVFGroup"). Figure 2A (left) shows V m (black line) and Ca i (red line) optical signals recorded during one of the SVF episodes. There were 2 postshock beats (1 and 2) before VF termination. Optical maps confirmed complete cessation of wave fronts after beat 2, consistent with type B successful defibrillation. 17 However, there was a large Ca i transient and short APD (beat 3). The first beat of SVF (beat 4) began during late phase 3 of the preceding sinus beat. In Figure 2A (b), an isochronal map illustrates that beat 4 originated from the basal portion of the RV. The right 2 columns are ratio maps of V m and Ca i , respectively, of the same beat. The Ca i remained elevated throughout the mapped field, whereas V m had already repolarized. The focal beat originated from the left upper quadrant during persistent Ca i elevation, consistent with the late phase 3 EAD mechanism. 5, 18 Five SVF episodes were recorded after initial successful defibrillation in this failing heart. Apamin prevented both the postshock APD shortening and SVF ( Figure 2B ). We repeated fibrillation/ defibrillation episodes four times, but no SVF was observed in the postshock period after apamin. Among the 12 failing ventricles studied, 3 developed a total of 11 episodes of SVF 104Ϯ23 seconds after initial successful defibrillation. Apamin administration completely prevented SVF after 3 to 5 repeated fibrillation/defibrillation episodes. 
Effects of Apamin on Baseline APD
Examples of APD 80 maps (bottom) and corresponding optical traces of action potentials from a single representative pixel (top) are presented in Figure 4A . Apamin induced more APD 80 prolongation in failing than in nonfailing ventricles at PCL of 300 ms. The APD prolongation predominantly occurred in the terminal portion of repolarization. Figure 4B shows the magnitude of APD 80 prolongation map obtained from the same nonfailing and failing ventricles presented in Figure 4A . At PCL of 300 ms, the percentage of APD prolongation with apamin was 5.4Ϯ0.7% for failing ventricles compared with 1.4Ϯ0.6% in nonfailing ventricles (PϽ0.05) ( Figure 4C ). A (a), Before apamin, a defibrillation shock (arrow) was followed by 2 postshock beats (1 and 2). Optical maps (not shown) confirmed complete cessation of wave fronts after beat 2, consistent with type B successful defibrillation. After a short pause, there was a large Ca i transient (red dot), short APD (beat 3), and first beat (beat 4) of SVF arising from late phase 3. A (b), Snapshots of Ca i and V m ratio maps at times from 10 ms before to 20 ms after the onset of beat 4. Note Ca i remained elevated throughout the mapped field, whereas V m has already repolarized. The beat 4 arose during persistently high Ca i and initiated the SVF. B, After apamin (1 mol/L) infusion, the postshock beats (5 and 6) had longer APD than the beats 1 to 4 in A. The APD and Ca i TD were approximately the same, and SVF episodes were completely prevented. PM indicates papillary muscle; S, interventricular septum; RV, right ventricle.
Effects of Apamin on APD After Rapid Pacing
We used rapid pacing to increase Ca i . After abrupt cessation of rapid ventricular pacing, APD shortening (⌬APD 80 ) was greater in failing than in nonfailing ventricles. The dependence of ⌬APD 80 on the PCL (Pacing Protocol I) and pacing duration (Pacing Protocol II) are presented in Figure 5 and Online Figure II , respectively. The shorter PCL and longer pacing duration elicited more APD shortening, and apamin reduced ⌬APD 80 after these rapid pacing protocols in failing ventricles. Figure 5A shows the effects of Pacing protocol I on ⌬APD 80 in a nonfailing ventricle at baseline (control) and after apamin administration. Figure 5B shows that apamin did not significantly change ⌬APD 80 in nonfailing ventricles. Figure 5C shows an example obtained from a failing ventricle with Pacing Protocol I. In this example, apamin reduced ⌬APD 80 from 23 ms to 8 ms. Figure 3D summarizes the effects of apamin in failing ventricles. Apamin significantly reduced ⌬APD 80 in failing but not in nonfailing ventricles. 
Effects of Apamin on Postshock APD in the No-SVF Group
In 9 of 12 failing ventricles, SVF did not occur after fibrillation/defibrillation episodes (the "no-SVF" Group). 5 Similar to the SVF Group, acute APD shortening was also observed in this group after a fibrillation/defibrillation episode. Figure 6A shows the optical tracing and corresponding APD 80 maps in SRm (left) and after defibrillation (right) in a failing ventricle without SVF. Similarly, apamin prolonged the APD immediately after defibrillation shock in failing ventricles that did not develop SVF ( Figure 6A, b) . Note the difference between Ca i TD 80 and APD 80 was reduced by apamin. In contrast, no acute shortening of APD was observed immediately after a successful defibrillation shock in nonfailing ventricles. Pretreatment with apamin did not result in significant APD changes in nonfailing ventricles ( Figure 6B ).
Postshock APD Changes of All Ventricles Studied
We plotted APD 80 of the first 2 postshock beats against the preceding diastolic interval (DI) for all episodes. Apamin did not change postshock APDs in nonfailing ventricles ( Figure  7A ), but prolonged postshock APDs significantly in failing ventricles of both the no-SVF Group ( Figure 7B ) and in the SVF Group ( Figure 7C ). We performed statistical analyses with repeated-measure ANOVA to compare the ⌬APD 80 before and after apamin. The ⌬APD 80 was 5.8 ms (-2.2 ms to 13.8 ms; PϭNS) for nonfailing ventricles, indicating that apamin did not significantly change the postshock APD. For In A and C, the first and third rows show action potential at fixed-rate pacing at 300 ms PCL. The second and fourth rows show action potentials during rapid pacing followed by a postpacing beat. The preceding cycle length of the first postpacing beat was controlled by an S 2 given 300 ms after the last S 1 . The APD of the first postpacing beat was measured to 80% repolarization (APD 80 ). The same pacing protocol was performed at baseline and after apamin (1 mol/L). B, Effect of apamin on ⌬APD 80 in all nonfailing ventricles studied. D, Effects of apamin in all failing ventricles studied. Bar graphs represent meansϮSEM; 1:1 indicates the shortest PCL associated with 1:1 capture. *PϽ0.05 vs control. We investigated the postshock APD 80 and the differences between Ca i TD 80 and APD 80 in all ventricles studied. The results are presented in Figure 7D and 7E, respectively. There were no significant differences in VF duration before versus after apamin in nonfailing ventricles (324Ϯ14 seconds versus 338Ϯ16 seconds, PϭNS), no-SVF (353Ϯ33 seconds versus 352Ϯ 44 seconds, PϭNS), and SVF (336Ϯ43 seconds versus 362Ϯ33 seconds, PϭNS) groups. Before apamin, the postshock APD 80 shortened to 147Ϯ2, 126Ϯ5, and 156Ϯ2 ms (PϽ0.05) in no-SVF group, SVF group, and nonfailing ventricles, respectively. Apamin minimized acute transient postshock APD 80 shortening in failing ventricles but not in nonfailing ventricles. Specifically, apamin increased postshock APD 80 in no-SVF group from 147Ϯ2 to 162Ϯ3 ms (PϽ0.05) and in SVF group from 126Ϯ5 to 153Ϯ4 ms (PϽ0.05). There was no change of APD 80 in nonfailing group before (156Ϯ2 ms) and after apamin (162Ϯ4 ms, PϭNS). The differences between Ca i TD 80 and APD 80 were also decreased with apamin in no-SVF (36Ϯ2 versus 22Ϯ3 ms, PϽ0.05) and SVF (77Ϯ8 versus 41Ϯ4 ms, PϽ0.05) groups but not in nonfailing group (27Ϯ2 versus 25Ϯ3 ms).
Effects of Glibenclamide on ⌬APD 80 in Failing Ventricles
To determine whether ATP-sensitive potassium current (I KATP ) activation was responsible for the APD shortening in failing ventricles, we examined the effect glibenclamide (10 mol/L), which mainly inhibit I KATP channel in this range of concentrations, 19 
I KAS in Failing Ventricles
The density and properties of I KAS were examined in cardiomyocytes isolated from normal and failing rabbit left ventricles using the voltage-clamp technique in whole-cell mode. Figure 8A shows representative current traces obtained with a step-pulse protocol (300 ms pulse duration; holding potential, Ϫ50 mV; see inset) in the absence and presence of 100 nmol/L apamin in the bath solution. Mean I KAS density (determined as the apamin-sensitive difference current) was significantly larger in failing than in normal ventricular epicardial myocytes (I KAS density at 0 mV with an intrapipette free Ca 2ϩ of 863 nmol/L: 8.39Ϯ1.00 pA/pF, nϭ6 cells from 5 failing rabbits, versus 2.83Ϯ0.87 pA/pF, nϭ6 cells from 4 normal rabbits, PϽ0.01). In contrast, when the intrapipette free-Ca 2ϩ was buffered to 100 nmol/L, the apamin-sensitive current was much smaller, with no significant difference between normal and failing ventricular myocytes ( Figure 8D ). Figure 8B illustrates the I KAS -voltage (I-V) relationships. Transmural distribution of I KAS in failing ventricles was studied using cardiomyocytes isolated from 3 layers (6 epicardial cells, 5 midmyocardial cells, and 7 endocardial cells from 5 animals). Mean I KAS density in epicardial myocytes (8.52Ϯ2.47 pA/pF, range 5.21 to 11.46 pA/pF) was significantly larger than midmyocardial cells (2.18Ϯ2.14 pA/pF, range 0.00 to 5.70 pA/pF) and endocardial cells (1.87Ϯ2.36 pA/pF, range 0.00 to 6.04 pA/pF) ( Figure 8C ). To further elucidate the mechanisms underlying I KAS upregulation, Ca 2ϩ -dependence of I KAS was studied in epicardial cells using pipette solutions containing increasing intracellular free Ca 2ϩ concentrations. Figure 8D demonstrates that the steady-state Ca 2ϩ response of I KAS was leftward-shifted in the failing cells compared with the normal cells. The data were fitted with the Hill equation, yielding K d of 232Ϯ5 nmol/L for failing and 553Ϯ78 nmol/L (Pϭ0.002) for normal cells, and Hill coefficients of 2.38Ϯ0.13 for failing and 1.50Ϯ0.30 for normal cells (Pϭ0.01). These results are compatible with the notion that the K ϩ channels carrying I KAS have increased sensitivity to cytosolic Ca 2ϩ in failing ventricles.
Quantitative PCR
The SK2 mRNA levels (normalized to GAPDH) in normal (Nϭ5) and failing (Nϭ5) ventricles were 100Ϯ16.4% and 118Ϯ8.5%, respectively (Pϭ0.39).
Discussion
The primary finding of this study is that heart failure heterogeneously increases the sensitivity of I KAS to intracellular Ca 2ϩ , leading to upregulation of I KAS , postshock APD shortening and recurrent SVF.
I KAS in the Normal and Failing Ventricles
The primary function SK channels in the nervous system is to produce afterhyperpolarization following a neural action potential and to protect the cell from the deleterious effects of continuous tetanic activity. 20 Seminal studies from multiple laboratories show that SK channels are also expressed in cardiac cells, more so in the atria than in the ventricles. 10 -16 These findings suggest that specific ligands for SK currents may offer a unique therapeutic opportunity to directly modify atrial cells without interfering with ventricular myocytes. 12 Our study confirmed that I KAS plays little role in APD regulation in normal ventricles. However, the same is not true for failing ventricles in which I KAS is upregulated in epicardial cells. Previous studies showed that multiple ventricular K ϩ currents (I to , I K1 , I Kr and I Ks ) are downregulated in animal models of HF, contributing to the reduced repolarization reserve. 21 In addition, ATP-sensitive K ϩ currents (I KATP ) are also disrupted in HF. The I KATP , which shortens APD and protects the heart from Ca i overload, is essential in maintaining the homeostasis during the metabolically demanding adaptive response to stress. 22 In a model of HF induced by transgenic expression of the cytokine tumor necrosis factor ␣, structural remodeling in failing ventricles led to disruption of energetic signal-channel communication, resulting in disturbing the I KATP -mediated protection. 23 Another study 24 shows that I KATP channel activation under metabolic stress was impaired in myocytes from rat hypertrophied ventricle. Our study found that suppression of I KATP did not reduce postpacing or postshock APD shortening in failing ventricles, but apamin significantly reduced the magnitude of postpacing or postshock APD shortening. Taken together, these findings suggest that because of I KATP channel malfunction and downregulation of multiple other K ϩ currents, the failing ventricles may rely on I KAS to shorten the APD in situations of Ca i overload.
Late Phase 3 EAD and Ventricular Arrhythmogenesis
When heart rate increases, APD shortens physiologically to preserve a sufficient diastolic interval for ventricular filling and coronary flow. However, excessive APD shortening might be arrhythmogenic by promoting late phase 3 EAD 18 or by inducing transmural heterogeneity of repolarization. 25 Because of SERCA downregulation 26 and decreased driving force of Na ϩ /Ca 2ϩ exchange current, 27 myocytes in failing hearts have higher diastolic Ca i concentration, slower Ca i transient decay, and more Ca i accumulation during burst pacing than those in normal hearts. Therefore, during rapid pacing or fibrillation in failing ventricles, the rapid depolarization may increase Ca i which in turn activates I KAS and shortens APD in a spatially heterogeneous fashion. Marked APD shortening after fibrillation/defibrillation episodes with persistent Ca i elevation during the late phase 3 of action potential results in the development of late phase 3 early afterdepolarization and recurrent SVF in failing hearts. 5 
Heterogeneous Remodeling of I KAS
The upregulation of I KAS during HF is highly heterogeneous. Although epicardial cells in average gained much more I KAS density than midmyocardial and endocardial cells during HF, large variations of I KAS density is present within the same layer of cells. Previous studies showed that strong intercellular coupling can reduce the differences of APD between different layers of cells, making M cells "invisible" in intact human ventricles. 28 Similarly, the highly heterogeneous distribution of I KAS density and the tight intercellular coupling of intact ventricles allowed cells with high I KAS density and shortened APD to influence the APD of the neighboring cells with low I KAS density. Therefore, optical mapping studies showed that postshock APD shortening occurs both in the epicardium and in the endocardium, and that apamin prevented postshock APD shortening in both layers of the ventricles.
Clinical Implications
Recurrent SVF (electrical storm) is a frequent complication in patients with advanced HF. 2 A recent genome-wide association study 29 showed that variants at the 1q21 locus cluster at KCNN3 (SK3) is associated with atrial fibrillation. The knowledge that I KAS is upregulated in HF should direct broader studies into the role of such currents in determining heart disease risk and as possible targets for preventive therapy in both atrial and ventricular arrhythmias.
Study Limitations
Apamin is a neural toxin and may induce significant neurological side effects when used in live animals and in humans. Therefore, it is necessary to develop nontoxic blockers of I KAS before we can test the effects of I KAS blockade on VF storm in human patients. Another limitation is that apamin is a potent inhibitor of the L-type Ca current (I Ca,L ). 30 Although I Ca,L blockade cannot be used to explain APD lengthening after fibrillation/defibrillation episodes, this pharmacological effect could help prevent SVF. Therefore, whether or not apamin prevented SVF by I KAS blockade or by a combined effects of I KAS and I Ca,L blockade remain unclear.
